Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CNAT

Conatus Pharmaceuticals (CNAT) Stock Price, News & Analysis

Conatus Pharmaceuticals logo

About Conatus Pharmaceuticals Stock (NASDAQ:CNAT)

Advanced Chart

Key Stats

Today's Range
$0.0003
$0.0003
50-Day Range
$0.56
$1.34
52-Week Range
$0.23
$1.07
Volume
14 shs
Average Volume
1.28 million shs
Market Capitalization
$9.95 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CNAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Conatus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CNAT Stock News Headlines

See More Headlines

CNAT Stock Analysis - Frequently Asked Questions

Conatus Pharmaceuticals Inc (NASDAQ:CNAT) issued its quarterly earnings data on Friday, May, 1st. The biotechnology company reported ($0.10) EPS for the quarter, hitting analysts' consensus estimates of ($0.10). Conatus Pharmaceuticals had a negative trailing twelve-month return on equity of 48.22% and a negative net margin of 52.42%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Conatus Pharmaceuticals investors own include KNOT Offshore Partners (KNOP), Trevena (TRVN), PPL (PPL), (CASC) (CASC), Vaxart (VXRT), Antares Pharma (ATRS) and Dextera Surgical (DXTR).

Company Calendar

Last Earnings
5/01/2020
Today
8/28/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CNAT
CIK
1383701
Fax
N/A
Employees
30
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$11.39 million
Net Margins
-52.42%
Pretax Margin
N/A
Return on Equity
-48.22%
Return on Assets
-39.32%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
16.28
Quick Ratio
16.28

Sales & Book Value

Annual Sales
$21.72 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.53 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
33,170,000
Free Float
N/A
Market Cap
$9.95 thousand
Optionable
Not Optionable
Beta
1.84
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:CNAT) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners